Palleon Pharmaceuticals
Peter Murray is on the faculty of the Max Planck Institute in Munich, Germany, where he is focused on immune regulation, particularly in macrophages. His lab is now translating his principles learned from infection biology to the cancer arena.
This person is not in the org chart
This person is not in any offices
Palleon Pharmaceuticals
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer.